Direct-to-brain chemo better than systemic drugs when immunotherapy is to follow

In experiments on mice with a form of aggressive brain cancer, researchers have shown that localized chemotherapy delivered directly to the brain rather than given systemically may be the best way to keep the immune system intact and strong when immunotherapy is also part of the treatment.